by Admin | February 8, 2013 4:07 pm
February 8, 2013—Hospitals that use 340B covered outpatient drugs in departments that treat both inpatients and outpatients cannot buy drugs for such units at group purchasing organization (GPO) prices and then replenish their inventories with drugs bought at 340B prices, the Health Resources and Services Administration (HRSA) said yesterday.
Hospitals have used this drug-purchasing model in so-called “mixed-use” settings such as emergency, surgical, and radiology departments for many years and its invalidation by HRSA’s Office of Pharmacy Affairs (OPA) is expected to cause considerable disruption.
Source URL: https://340binformed.org/2013/02/hrsa-clarifies-policy-on-340b-hospitals-use-of-gpos/
Copyright ©2026 340binformed.org unless otherwise noted.